Bone Marrow Immunity and Myelodysplasia.

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• Myelodysplastic syndrome (MDS) is characterized by ineffective hematopoiesis, aberrant clone production, and high bone marrow (BM) cell apoptosis.
• Bone marrow harbors a complex cellular environment including hematopoietic stem cells, precursors, and mature immune cells like macrophages, T cells, and NK cells.
• Immune cells, including macrophages and T cells, are crucial for immunosurveillance and clearing cellular debris, but their precise roles in MDS are not fully understood.

Purpose of the Study:

• To investigate the complex role of immune cells within the bone marrow microenvironment in the context of Myelodysplastic syndrome (MDS).
• To explore the cytotoxic potential of specific T cell subsets and their cytokine profiles in MDS.
• To understand the implications of immune cell activity on MDS progression, cytopenia, and myelofibrosis.

Main Methods:

• Analysis of bone marrow (BM) cell populations and their characteristics in MDS patients.
• Characterization of the cytokine signature of specific T cell subsets, such as BM CD8(+) CD28(-) CD57(+) T cells.
• Investigation of the role of stromal cells and other immune components like myeloid-derived suppressor cells (MDSC) in the BM microenvironment.

Main Results:

• Bone marrow CD8(+) CD28(-) CD57(+) T cells exhibit direct cytotoxicity and a distinct cytokine profile (e.g., TNF-α, IL-6, CCL3, CCL4) that promotes aberrant cell apoptosis.
• These cytotoxic T cells, along with TGF-β, can exacerbate MDS-related cytopenia and myelofibrosis.
• Interleukin-32 (IL-32) produced by stromal cells enhances NK cell cytotoxicity and contributes to a pro-inflammatory cytokine loop.

Conclusions:

• Immune cells, especially cytotoxic T cells, have a dual role in MDS, offering potential protection while also contributing to disease pathology.
• Targeting specific immune cell populations or their mediators (e.g., CD33 on stem cells) may offer novel biotherapeutic strategies for MDS.
• MDS impacts systemic immunity, potentially leading to chronic inflammation and autoimmune disorders, highlighting the intricate relationship between MDS and immune dysregulation.